However, we recently showed that the purified Omomyc miniprotein displays cell-penetrating properties and has the innate capacity to enter NSCLC cells, reach their nuclei and interfere with MYC transcriptional activity, causing a therapeutic impact in mouse models of lung cancer (41). The gene discussed is MYC; the disease is lung cancer.